Protocol CY 5021: A Phase 2, Double-blind, Randomized, Placebo-Controlled, Multiple Dose Study of CK-2127107 in Two Ascending Dose Cohorts of Patients with Spinal Muscular Atrophy (SMA)

Krosschell, Kristin (PD/PI)

Physical Therapy and Human Movement Sciences

Project: Research project

Status	Finished
Effective start/end date	1/16/18 → 1/16/21

Funding

Ann & Robert H. Lurie Children's Hospital of Chicago (Protocol CY 5021 // Protocol CY 5021)
Cytokinetics, Inc. (Protocol CY 5021 // Protocol CY 5021)